Skip to content

Clinical trial comparing the efficacy of Errorless Naming Treatment and Combining Inhibitory Control Treatment upon word retrieval difficulties in patients with aphasia

The efficacy of Combining Inhibitory Control Treatment into an Errorless Naming Treatment upon word retrieval difficulties in patients with aphasia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017042933682N1
Enrollment
20
Registered
2017-06-02
Start date
2017-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aphasia. progressive isolated aphasia

Interventions

Intervention 1: Intervention group: The Combining Inhibitory Control Treatment. Treatment Duration: 4 successive weeks, 3 sessions per week, each session 45-60 minutes. Intervention 2: Control group:
Treatment - Other
Intervention group: The Combining Inhibitory Control Treatment. Treatment Duration: 4 successive weeks, 3 sessions per week, each session 45-60 minutes
Control group: Errorless Naming Treatment Treatment Duration: 4 successive weeks, 3 sessions per week, each session 45-60 minutes

Sponsors

Vice chancellor for research of Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Proficiency in Persian language; Right-handedness; The range of age is 20 to 65 years; Having elementary literacy; Both genders; Cerebro Vascular Accident(CVA) is created in frontal or sub cortical structures in the left hemisphere; The dominant and sustainable language impairment along with Preservation of other mental functions(memory, attention, visual spatial deficits using Persian Aphasia diagnostic test (clinical version) and Mississippi test; Aphasia is not caused by factors such as trauma, metabolic disorders, and infection; Having no acute neurological or psychiatric problems; At least 6 months post-stroke; Having naming deficit (chief complain); Having auditory and visual acuity (with or without corrective device); Having no severe Apraxia; Having no severe Dysarthria. Exclusion criteria: If patient or his/her family would not continue the treatment and or; If patient during the treatment suffers from a new stroke or another neurological condition, he/she would be excluded.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The ability to name pictures. Timepoint: Pre intervention, Post intervention, 1 month after intervention. Method of measurement: The score of Picture naming test.;The ability to match Spoken word, picture. Timepoint: Pre intervention, Post intervention, 1 month after interventioP. Method of measurement: The score of spoken word, picture matching test.;The ability to repeat word, non word. Timepoint: Pre intervention, Post intervention, 1 month after intervention. Method of measurement: The score of word, non word repetition test.;The ability of communicative effectiveness. Timepoint: Pre intervention, Post intervention, 1 month after intervention. Method of measurement: The score of the communicative effectiveness index.

Secondary

MeasureTime frame
The ability of inhibitory control. Timepoint: Pre intervention, Post intervention, 1 month after intervention. Method of measurement: The score of Stroop test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRezvan Akbari Manie

Speech Therapy Department, School of Rehabilitation, Tehran University of Medical Sciences

r-akbarimani@razi.tums.ac.ir+98 21776366042

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026